Welcome to LookChem.com Sign In|Join Free
  • or
(16,18-dioxo-17-azapentacyclo[6.6.5.0~2,7~.0~9,14~.0~15,19~]nonadeca-2,4,6,9,11,13-hexaen-17-yl)acetic acid (non-preferred name) is a complex organic molecule characterized by a seven-membered nitrogen-containing ring and a carboxylic acid group. This intricate structure suggests potential involvement in biochemical processes and applications in pharmacology and medicinal chemistry.

5472-26-4

Post Buying Request

5472-26-4 Suppliers

Recommended suppliers

  • Product
  • FOB Price
  • Min.Order
  • Supply Ability
  • Supplier
  • Contact Supplier

5472-26-4 Usage

Uses

Used in Pharmaceutical Industry:
(16,18-dioxo-17-azapentacyclo[6.6.5.0~2,7~.0~9,14~.0~15,19~]nonadeca-2,4,6,9,11,13-hexaen-17-yl)acetic acid (non-preferred name) is used as a potential pharmaceutical agent for its involvement in biochemical processes. Its specific molecular structure and interactions may offer unique properties for the development of new drugs and therapies.
Used in Medicinal Chemistry Research:
In the field of medicinal chemistry, (16,18-dioxo-17-azapentacyclo[6.6.5.0~2,7~.0~9,14~.0~15,19~]nonadeca-2,4,6,9,11,13-hexaen-17-yl)acetic acid (non-preferred name) serves as a subject of study for understanding its properties and exploring its potential applications. Further research and analysis are necessary to fully harness its capabilities in drug discovery and development.

Check Digit Verification of cas no

The CAS Registry Mumber 5472-26-4 includes 7 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 4 digits, 5,4,7 and 2 respectively; the second part has 2 digits, 2 and 6 respectively.
Calculate Digit Verification of CAS Registry Number 5472-26:
(6*5)+(5*4)+(4*7)+(3*2)+(2*2)+(1*6)=94
94 % 10 = 4
So 5472-26-4 is a valid CAS Registry Number.

5472-26-4Relevant academic research and scientific papers

Synthesis, anti-inflammatory and analgesic evaluation of certain new 3a,4,9,9a-tetrahydro-4,9-benzenobenz[f]isoindole-1,3-diones

Abu-Hashem,Gouda

scheme or table, p. 543 - 551 (2011/10/19)

In an effort to establish new candidates with improved analgesic and anti-inflammatory activities, we reported here the synthesis and in-vivo analgesic and anti-inflammatory evaluation of various series of 2-substituted-3a,4,9,9a-tetrahydro-4,9-benzeno-be

Modular Design of Hosts Involving a Rigid Succinimide Framework and N-Bonded Lateral Groups. Crystalline Inclusion Properties and Crystal Structures of Inclusion Compounds with Dioxane, MeOH, and DMF

Weber, Edwin,Finge, Stephan,Csoeregh, Ingeborg

, p. 7281 - 7288 (2007/10/02)

A series of crystalline host molecules comprising a characteristic 9,10-dihydro-9,10-ethanoanthracene-11,12-dicarboxamide framework have been synthesized and studied with regard to their inclusion behavior.They follow a new design concept which is to conv

Post a RFQ

Enter 15 to 2000 letters.Word count: 0 letters

Attach files(File Format: Jpeg, Jpg, Gif, Png, PDF, PPT, Zip, Rar,Word or Excel Maximum File Size: 3MB)

1 Customer Service

What can I do for you?
Get Best Price

Get Best Price for 5472-26-4